Clover Health Investments, Corp.
CLOV
$3.10
-$0.07-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.46B | 1.34B | 1.32B | 1.30B | 1.27B |
| Total Other Revenue | 26.48M | 25.78M | 24.09M | 20.48M | 19.88M |
| Total Revenue | 1.49B | 1.37B | 1.34B | 1.32B | 1.29B |
| Cost of Revenue | 1.09B | 1.01B | 1.01B | 999.05M | 994.96M |
| Gross Profit | 391.93M | 364.34M | 329.01M | 317.65M | 290.75M |
| SG&A Expenses | 414.84M | 408.93M | 401.79M | 413.19M | 417.41M |
| Depreciation & Amortization | 1.48M | 1.33M | 1.66M | 1.88M | 2.55M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.51B | 1.42B | 1.42B | 1.41B | 1.41B |
| Operating Income | -24.39M | -45.93M | -74.44M | -97.42M | -129.22M |
| Income Before Tax | -24.37M | -46.27M | -92.73M | -117.56M | -153.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.37 | -46.27 | -92.73 | -117.56 | -153.62 |
| Earnings from Discontinued Operations | -743.00K | 3.26M | 1.34M | -6.14M | -6.31M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.11M | -43.01M | -91.39M | -123.70M | -159.93M |
| EBIT | -24.39M | -45.93M | -74.44M | -97.42M | -129.22M |
| EBITDA | -22.91M | -44.60M | -72.78M | -95.54M | -126.67M |
| EPS Basic | -0.05 | -0.09 | -0.19 | -0.26 | -0.33 |
| Normalized Basic EPS | -0.03 | -0.06 | -0.10 | -0.13 | -0.17 |
| EPS Diluted | -0.06 | -0.10 | -0.20 | -0.26 | -0.33 |
| Normalized Diluted EPS | -0.03 | -0.06 | -0.10 | -0.13 | -0.17 |
| Average Basic Shares Outstanding | 1.97B | 1.96B | 1.95B | 1.94B | 1.93B |
| Average Diluted Shares Outstanding | 1.97B | 1.96B | 1.95B | 1.94B | 1.93B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |